Beyond the Majority: Rethinking Treatment for Rare Ovarian Cancer Subtypes

Wednesday, January 27, 2027 at 5:00 PM to 5:30 PM · 30 min. (Europe/London)
Women & Children's Health Stage
Day 1 - Wednesday 27th January
CancerWomen & Children's Health

Information

  • Ovarian cancer is not one disease: understanding the distinct biology and clinical needs of different ovarian cancer subtypes. 
  • The overlooked 25%: why rarer subtypes such as low-grade serous ovarian cancer remain underrepresented in research and clinical trials. 
  • Using genomics to uncover new opportunities: what genomic approaches can reveal about rare ovarian cancers and potential therapeutic vulnerabilities. 
  • From discovery to treatment: translating molecular insights into new treatment strategies and clinical trials for patients with rarer disease. 
  • The future of precision treatment: overcoming resistance and exploring emerging therapies, including antibody-drug conjugates, to improve outcomes across ovarian cancer subtypes.